Interaction of natural killer cells with MHC class II: Reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A

Immunology

Volumn 87, Issue 3, 1996, Pages 481-486

  Jiang, Y Z ^a,c   Couriel, D ^a   Mavroudis, D A ^a   Lewalle, P ^a   Malkovska, V ^b   Hensel, N F ^a   Dermime, S ^a   Molldrem, J ^a   Barrett, A J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CHLOROQUINE; HLA DR ANTIGEN;

ADULT; ARTICLE; CELL LINE; CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029990146     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.483556.x     Document Type: Article

References (28)

1. HERBERMAN R.B., DJEU J.Y., KAY D.H. et al. (1979) Natural killer cells: characteriztics and regulation of activity. Immunol Rev 44, 43.
2. HERBERMAN R.B., REYNOLDS C.W. & ORTALDO J.R. (1986) Mechanism of cytotoxocity by natural killer cells. Annu Rev Immunol 4, 651.
3. GILDLUND M., ORN A., PATTENGAL P.K., JANSSON M., WIGZELL H. & NILLSSON K. (1981) Natural killer cells kill tumour cells at a given stage of differentiation. Nature 292, 848.
4. LJUNGGREN H.G. & KARRE K. (1990) In search of the missing self: MHC molecules and NK cell recognition. Immunol Today 11, 237.
5. YU Y.L., KUMAR V. & BENNETT M. (1992) Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 10, 189.
6. BORDIGNON C., DALEY J.P. & NAKAMURA I. (1985) Hematopoietic histo-incompatibility reactions by NK cells in vitro: model for genetic resistance to marrow grafts. Science 230, 1398.
7. STORKUS W.J., HOWELL D.N., SALTER R.D., DAWSON J.R. & CRESSWELL P. (1987) NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 138, 1657.
8. HAREL-BELLAN A., QUILLET A., MARCHIOL C., DEMARS R., TURSZ T. & FRADELIZI D. (1986) Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6. Proc Natl Acad Sci USA 83, 5688.
9. STORKUS W.J., ALEXANDER J., PAYNE J.A., DAWSON J.R. & CRESSWELL P. (1989) Reversal of natural killing susceptibility in target cells expressing transfected class 1 HLA genes. Proc Natl Acad Sci USA. 86, 2361.
10. LEIDEN J.M., KARPINSKI B.A., GOTTSCHALK L. & KORNBLUTH J. (1989) Susceptibility to natural killer cell- mediated cytolysis is independent of the level of target cell class I HLA expression. J Immunol 142, 2140.
11. CHERVENAK R. & WOLCOTT R.M. (1988) Target cell expression of MHC antigens is not (always) a turn-off signal to natural killer cells. J Immunol 140, 3712.
12. SHIMIZU Y. & DEMARS R. (1989) Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur J Immunol 19, 447.
13. MORETTA A., VITALE M., BOTTINO C., ORENGO A.M. & MORETTA L. (1993) P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 178, 597.
14. LITWIN V., GUMPERZ J., PARHAM P., PHILLIPS J.H. & LANIER L.L. (1994) NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 180, 537.
15. CHADWICK B.S. & MILLER R.G. (1992) Hybrid resistance in vitro: possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol 148, 2307.
16. KAUFMAN D.S., SCHOON R.A. & LEIBSON P.J.(1992) Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. Proc Natl Acad Sci USA 89, 8337.
17. MALNATI M.S., PERUZZI M., PARKER K.C. et al. (1995) Peptide specifity in the recognition of MHC class I by natural killer cell clones. Science 267, 1016.
18. KURAGO Z.B., SMITH K.D. & CHARLES T.L. (1995) NK cell recognition of MHC class I: NK cells are sensitive to peptide-binding groove and surface α-helical mutations that affect T cells. J Immunol 154, 2631.
19. LOBO P.I. & SPENCER C.E. (1989) Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumour cells can enhance susceptibility of these cells to lysis by natural killer cells. J Clin Invest 83, 278.
20. LOBO P.I. & PATEL H.C. (1994) A novel role for MHC class II antigens: evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cells. Immunology 83, 240.
21. LONG E.O., ROSEN-BRONSON S., KARP D.R., MALNATI M., SEKALY R.P. & JARAQUEMADA D. (1991) Efficient cDNA expression vector for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cells. Human Immunol 31, 229.
22. WANG X.M., TERASAKI P.I., RANKIN G.W., CHIA D., ZHONG H.P. & HARDY S. (1993) A new microcellular cytotoxicity test based on Calcein AM release. Human Immunol 34, 264.
23. NELSON D.L., KURMAN C.C. & SERBOUSEK D.E. (1994) Cr-release assay of antibody-dependent cell mediated cytotoxicity. In: Current Protocols in Immunology (eds J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach & W. Strober), Vol. 1. National Institute of Health, Bethesda, MD.
24. TAKATSUKI A. & TAMURA G. (1985) Brefeldin A, a specific inhibitor of intracellular translocation of vesicular stomatitis virus G protein: intracellular accumulation of high-mannose type G protein and inhibition of its cell surface expression. Agric Biol Chem 49, 899.
25. MISUMI Y., MISUMI Y., MIKI K., TAKATSUKI A., TAMURA G. & IKEHARA Y. (1986) Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem 261, 11398.
26. PINET V., MALNATI M.S. & LONG E.O. (1994) Two processing pathways for the MHC class II restricted presentation of exogenous influenza virus antigen. J Immunol 152, 4852.
27. NUCHTERN J.G., BIDDISON W.E. & KLAUSNER R.D. (1990) Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 343, 74.
28. RUDENSKY A.Y., PRESTON-HURLBURT P., HONG S.-C., BARLOW A. & JANEWAY C.A. (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622.